Therme Wien Med
Vienna, Austria
Location status: Recruiting
Location contact
Stephan Nopp, MD
CONTACT
NCT Number: NCT04615130
This study is a multicenter, parallel, randomized waitlist-controlled trial that primarily focuses on the short-term benefit of outpatient pulmonary rehabilitation (PR) on patients after acute pulmonary embolism.
Patients will be randomized into an intervention and a control group. The intervention group will receive 6 weeks of outpatient PR, while patients in the other treatment arm will serve as a control. After completion of the randomized study, the second arm will undergo PR as well.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Not applicable
Vienna, Austria
Location status: Recruiting
Stephan Nopp, MD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Additional criteria that are absolute contraindications for pulmonary rehabilitation
Rehabilitation, exercise training
Time frame: within the 6-week study period
change of walking distance covered within 6 minutes before and after the intervention/control period, measured in meters
Time frame: within the 6-week study period
change of peak oxygen uptake (VO2/kg/min) measured by lung spiroergometry
Time frame: within the 6-week study period
change of maximal workload in cycle ergometer tests measured in Watt
Time frame: within the 6-week study period
change of one-repetition maximum for lower extremities measured in kg
Time frame: within the 6-week study period
change of one-repetition maximum for upper extremities measured in kg
Time frame: within the 6-week study period
change in maximum inspiratory muscle pressure measured in mbar
Time frame: within the 6-week study period
change in inspiratory muscle endurance measured in seconds
Time frame: within the 6-week study period
change in dyspea at rest and maximal exertion mesured with the medical research council scale and BORG scale
Time frame: within the 6-week study period
change of quality of life measured with the 5-level EQ-5D version (EQ-5D-5L)
Time frame: within the 6-week study period
change of quality of life measured with the Pulmonary Embolism Quality of Life (PEmb-QoL)
Time frame: within the 6-week study period
change of functional status measured with the patient reported outcomes measurement information system (PROMIS) physical function short form
Time frame: within the 6-week study period
change of functional status measured with the post-VTE functional status scale (min: 0, max: 4, lower scores indicate better functional status)
Time frame: within the 6-week study period
change in anxiety and depression measured with the hospital anxiety and depression scale (HADS)
Contact information is provided by the study sponsor or research team.
Medical University of Vienna
Other
Investigation of Outpatient PUlmonary REhabilitation in Patients Suffering From Post-PE Syndrome: a Randomized Waitlist-controlled Trial - the PURE-PE Study
Acronym: PURE-PE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07350499
Arterial Thromboembolism, Cardiovascular Diseases
Huntsville, Alabama, United States
View Trial DetailsNCT06041594
Cardiovascular Diseases, Embolism
Birmingham, Alabama, United States
View Trial DetailsNCT06433011
Cardiovascular Diseases, Embolism
Scottsdale, Arizona, United States
View Trial DetailsNCT06588634
Cardiovascular Diseases, Embolism
New Haven, Connecticut, United States
View Trial Details